Clinical Trial Update: Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring dopaminergic mechanisms of memory impairment in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Memory Impairment
• Parkinson Disease

Snippet

Sponsor: Peking University Third Hospital | Conditions: Parkinson Disease, Memory Impairment | Phase 4 | Status: UNKNOWN